Remove Distribution Remove Insurance Remove Networking
article thumbnail

Network Optimization Strategies for Payers: A Look at Provider Network Adequacy

Clarify Health

A well-balanced and adequately resourced provider network is a strategic asset for payers in the highly competitive healthcare insurance market. When looking to optimize, it is critical to ensure network adequacy or the provider network’s ability to meet the healthcare needs of an insured population.

article thumbnail

Pharma Marketing Resources

Pharma Marketing Network

Adhering to the Health Insurance Portability and Accountability Act (HIPAA) ensures that all marketing activities respect patient privacy. Organizations like Pharma Marketing Network offer in-depth articles that help marketers tailor their strategies to real patient needs. Join the Pharma Marketing Network community on Linkedin.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Role of Blockchain Technology in Healthcare Data Security

Referral MD

Blockchain technology addresses patients’ and medical staff’s need for secure data recording, transmission, and consultation over networks. First, blockchain’s distributed ledger technology improves data security by eliminating central authority. Personalized medicine and wearables raise data protection concerns.

article thumbnail

Scott Burrows: National Association Inspirational Keynote Speaker

Scott Burrows

In his professional life, Scott’s transition from the insurance and financial industry to building a successful multi-million dollar business in the golf course fertilizer sector highlights his ability to turn challenges into opportunities and drive innovation.

article thumbnail

Stakeholder Mapping for Pharmaceutical Products

Celeritas

Medical Science Liaisons are hired or contracted to meet with these stakeholders prior to and during the launch and distribution period to educate and create awareness of the drug. Begin the stakeholder mapping process by making a precise list of actors who will play a part in the pharmaceutical distribution process.

article thumbnail

Provention’s Tzield can delay type 1 diabetes. But will it reach all patients?

Pharmaceutical Technology

The international T1D network TrialNet’s research was instrumental in the FDA’s approval of the first drug to delay T1D in at-risk people. A 2022 research study identified lower socioeconomic status, education level, non-White race, and noncommercial insurance as key variables that limit access to technology supporting patients with T1D.

article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

Taken together, this all leads to eye-popping costs for the drug sponsor and of course for the patient and relevant insurance provider. As such, life science enterprises should seek to be well networked and continually ask themselves if they have the know-how, facilities, and technology to double down on CGT trials.